4//SEC Filing
SEELEY BRUCE J. 4
Accession 0000891293-18-000057
CIK 0000891293other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:35 PM ET
Size
5.4 KB
Accession
0000891293-18-000057
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2018-05-16+134,906→ 134,906 totalExercise: $4.14Exp: 2028-05-16→ Common Stock (134,906 underlying)
Footnotes (1)
- [F1]The stock option will vest in six equal semi-annual installments over a three-year period commencing on March 9, 2018 subject to continued employment with the Company through the applicable vesting dates, such that the option will be fully vested on March 9, 2021.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001474462
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:35 PM ET
- Size
- 5.4 KB